Literature DB >> 15009432

Allelic distribution of human leucocyte antigen in historical and recently diagnosed tuberculosis patients in Southern Italy.

Giuseppina Ruggiero1, Elena Cosentini, Delia Zanzi, Veronica Sanna, Giuseppe Terrazzano, Giuseppe Matarese, Alessandro Sanduzzi, Francesco Perna, Serafino Zappacosta.   

Abstract

This study addresses the analysis of the human leucocyte antigen (HLA) allele distribution in 54 historical and in 68 recently diagnosed tuberculosis (TB) patients. The historical cohort was characterized by the presence of large fibrocavernous lesions effectively treated with therapeutic pneumothorax during the period 1950-55. Patients and healthy controls enrolled in the study were from the Campania region of southern Italy. No significant association between HLA alleles and TB in the population of recently diagnosed TB patients was observed. On the contrary, among the historical TB patients there was a strong association with an increased frequency of the HLA-DR4 allele alone and/or in the presence of the HLA-B14 allele (P = 0.000004; Pc = 0.0008), as well as with a decreased frequency of the HLA-A2+,-B14-,DR4- allele association (P = 0.00005; Pc = 0.01). In order to exclude any interference from age-related factors, these results were confirmed by comparing the historical cohort of TB patients with an age-matched healthy control population of the same ethnic origin (P = 0.00004; Pc = 0.008; and P = 0.0001; and Pc = 0.02, respectively).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009432      PMCID: PMC1782420          DOI: 10.1111/j.1365-2567.2004.01811.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

Review 1.  Susceptibility to mycobacterial infections: the importance of host genetics.

Authors:  R Bellamy
Journal:  Genes Immun       Date:  2003-01       Impact factor: 2.676

2.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

3.  Association of pulmonary tuberculosis and HLA in south India.

Authors:  V Brahmajothi; R M Pitchappan; V N Kakkanaiah; M Sashidhar; K Rajaram; S Ramu; K Palanimurugan; C N Paramasivan; R Prabhakar
Journal:  Tubercle       Date:  1991-06

4.  Artificial pneumothorax: a statistical analysis of 557 cases initiated in 1930-1939 and followed in 1949. II. The fate of the contralateral lung.

Authors:  R S MITCHELL
Journal:  Am Rev Tuberc       Date:  1951-07

5.  Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis?

Authors:  T H Ottenhoff; P Torres; J T de las Aguas; R Fernandez; W van Eden; R R de Vries; J L Stanford
Journal:  Lancet       Date:  1986-08-09       Impact factor: 79.321

6.  Genetic control of survival in epidemics.

Authors:  R R de Vries; P Meera Khan; L F Bernini; E van Loghem; J J van Rood
Journal:  J Immunogenet       Date:  1979-08

7.  The surgery for pulmonary tuberculosis.

Authors:  E A Gaensler
Journal:  Am Rev Respir Dis       Date:  1982-03

8.  Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.

Authors:  D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

9.  Marek's disease: effects of B histocompatibility alloalleles in resistant and susceptible chicken lines.

Authors:  W E Briles; H A Stone; R K Cole
Journal:  Science       Date:  1977-01-14       Impact factor: 47.728

10.  Common west African HLA antigens are associated with protection from severe malaria.

Authors:  A V Hill; C E Allsopp; D Kwiatkowski; N M Anstey; P Twumasi; P A Rowe; S Bennett; D Brewster; A J McMichael; B M Greenwood
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

View more
  7 in total

1.  Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401.

Authors:  Simani Gaseitsiwe; Davide Valentini; Shahnaz Mahdavifar; Marie Reilly; Anneka Ehrnst; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

2.  [Association between HLA-A and HLA-DRB1 allele polymorphisms and susceptibility to tuberculosis in southern Chinese population].

Authors:  Chunxin Liao; Jiahui Yang; Jinli Wang; Xialin Du; Ruining Wang; Shimeng Zhang; Wenting He; Qian Wen; Li Ma
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-01-30

3.  Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population.

Authors:  Dhêmerson Souza de Lima; Mauricio Morishi Ogusku; Maisa Porto Dos Santos; Cláudia Maria de Melo Silva; Vanessa Alves de Almeida; Irineide Assumpção Antunes; Antonio Luiz Boechat; Rajendranath Ramasawmy; Aya Sadahiro
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

Review 4.  The Research Progress of Host Genes and Tuberculosis Susceptibility.

Authors:  Li Cai; Zhan Li; Xuhua Guan; Kun Cai; Lei Wang; Jiafa Liu; Yeqing Tong
Journal:  Oxid Med Cell Longev       Date:  2019-08-14       Impact factor: 6.543

5.  An analysis of the epitope knowledge related to Mycobacteria.

Authors:  Martin J Blythe; Qing Zhang; Kerrie Vaughan; Romulo de Castro; Nima Salimi; Huynh-Hoa Bui; David M Lewinsohn; Joel D Ernst; Bjoern Peters; Alessandro Sette
Journal:  Immunome Res       Date:  2007-12-14

Review 6.  Influence of Genetic Polymorphism Towards Pulmonary Tuberculosis Susceptibility.

Authors:  Murugesan Harishankar; Paramasivam Selvaraj; Ramalingam Bethunaickan
Journal:  Front Med (Lausanne)       Date:  2018-08-16

7.  Serafino Zappacosta: An Enlightened Mentor and Educator.

Authors:  Ennio Carbone; Mario De Felice; Francesca Di Rosa; Ugo D'Oro; Silvia Fontana; Antonio La Cava; Michele Maio; Giuseppe Matarese; Luigi Racioppi; Giuseppina Ruggiero; Giuseppe Terrazzano
Journal:  Front Immunol       Date:  2020-02-13       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.